BMRN vs VTVT · P/E 40, rev $1.76B vs rev $36.8M
Biomarin Pharmaceutical Inc (BMRN) versus vTv Therapeutics Inc (VTVT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
vTv Therapeutics Inc (VTVT) is a biotechnology company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported VTVT revenue for 2026-06-30 was $36.8M. Net income was $11.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. VTVT currently screens at market cap $133.9M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. VTVT currently screens at market cap $133.9M.
Not investment advice. Open the BMRN and VTVT stock pages for the full models.
Not investment advice.